Foghorn Therapeutics Inc (FHTX) — Strategic Asset Allocation Index
Foghorn Therapeutics Inc (FHTX) has a Strategic Asset Allocation Index of 44104.5% as of December 2022. Strategic assets (PP&E of $49.40 Million plus long-term investments of $-) total $49.40 Million, measured against net assets of $112.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Foghorn Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Foghorn Therapeutics Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Foghorn Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 44104.5%, representing strategic assets of $49.40 Million against net assets of $112.00K USD. For live market cap and overall valuation, see FHTX stock market capitalisation.
Annual Strategic Asset Allocation Index for Foghorn Therapeutics Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Foghorn Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See FHTX total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44104.5% | $49.40 Million | $49.40 Million | $- | $112.00K | ▲ +44046.6 pp |
| 2021 | 57.9% | $56.08 Million | $56.08 Million | $- | $96.87 Million | ▲ +15.3 pp |
| 2020 | 42.6% | $62.33 Million | $62.33 Million | $- | $146.19 Million | — |